---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-25-098281"
form_type: "8-K"
ticker: "BJDX"
cik: "0001704287"
company_name: "Bluejay Diagnostics, Inc."
filed_at: "2025-10-14T23:59:59+00:00"
generated_at: "2026-05-17T03:54:55.878957+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Bluejay Diagnostics raises $4.5M in private placement of stock and warrants

## Summary
- Gross proceeds of $4.5M; net proceeds ~$4.0M after 8% placement agent fee and expenses.
- Issued 2.25M shares/pre-funded warrants at $2.00/unit plus Series F warrants for 4.5M shares at $1.75.
- Net proceeds to fund FDA approval efforts, clinical studies, R&D, and working capital.
- Rodman & Renshaw acted as exclusive placement agent; warrants include 4.99%/9.99% beneficial ownership caps.
- Company agreed to file resale registration statement by Oct 24, 2025, and has 90-day issuance lock-up post-effectiveness.

## SEC filing metadata
- accession: 0001213900-25-098281
- form_type: 8-K
- ticker: BJDX
- cik: 0001704287
- company_name: Bluejay Diagnostics, Inc.
- filed_at: 2025-10-14T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 3.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1704287/000121390025098281/0001213900-25-098281-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1704287/000121390025098281/ea0260965-8k_bluejay.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-25-098281
- JSON: https://secwatch.observer/filing/0001213900-25-098281.json
- Plain text: https://secwatch.observer/filing/0001213900-25-098281.txt

## Key facts
- Equity Issuances
  Bluejay Diagnostics, Inc. issued 175,000 shares of common stock to institutional, accredited investors for $2.00 per share.
  - Security: common stock
  - Shares: 175,000 shares
  - Purchaser: institutional, accredited investors
  - Consideration: $2.00 per share
  source text: and (ii) Series F warrants (“Series F Warrants”) to purchase up to 4,500,000 shares of common stock. The combined price of securities sold in the private placement was $2.00 per share of common stock (or pre-funded warrant in lieu thereof, in which case such price was reduced by $0.0001) and accompanying Series F Warrants to acquire two shares of
  evidence_url: https://www.sec.gov/Archives/edgar/data/1704287/000121390025098281/0001213900-25-098281-index.htm
- Equity Issuances
  Bluejay Diagnostics, Inc. issued Placement Agent Warrants to purchase up to an aggregate of 180,000 shares of common stock of warrant to Rodman and Renshaw LLC (placement agent) for 125% of the combined price per share.
  - Security: warrant
  - Shares: Placement Agent Warrants to purchase up to an aggregate of 180,000 shares of common stock
  - Purchaser: Rodman and Renshaw LLC (placement agent)
  - Consideration: 125% of the combined price per share
  source text: the “common warrants”) to purchase up to an aggregate of 180,000 shares of common stock on the same terms as the Series F Warrants, except that the exercise price per share is 125% of the combined price per share and Series F Warrants sold in the offering. Pursuant to the terms of the registration rights agreement, the Company has agreed to register for
  evidence_url: https://www.sec.gov/Archives/edgar/data/1704287/000121390025098281/0001213900-25-098281-index.htm
- Equity Issuances
  Bluejay Diagnostics, Inc. issued Series F Warrants to purchase up to 4,500,000 shares of common stock of warrant to institutional, accredited investors for $2.00 per share.
  - Security: warrant
  - Shares: Series F Warrants to purchase up to 4,500,000 shares of common stock
  - Purchaser: institutional, accredited investors
  - Consideration: $2.00 per share
  source text: and (ii) Series F warrants (“Series F Warrants”) to purchase up to 4,500,000 shares of common stock. The combined price of securities sold in the private placement was $2.00 per share of common stock (or pre-funded warrant in lieu thereof, in which case such price was reduced by $0.0001) and accompanying Series F Warrants to acquire two shares of
  evidence_url: https://www.sec.gov/Archives/edgar/data/1704287/000121390025098281/0001213900-25-098281-index.htm
- Equity Issuances
  Bluejay Diagnostics, Inc. issued Pre-Funded Warrants to purchase up to 2,075,000 shares of common stock of warrant to institutional, accredited investors for $2.00 per share.
  - Security: warrant
  - Shares: Pre-Funded Warrants to purchase up to 2,075,000 shares of common stock
  - Purchaser: institutional, accredited investors
  - Consideration: $2.00 per share
  source text: and (ii) Series F warrants (“Series F Warrants”) to purchase up to 4,500,000 shares of common stock. The combined price of securities sold in the private placement was $2.00 per share of common stock (or pre-funded warrant in lieu thereof, in which case such price was reduced by $0.0001) and accompanying Series F Warrants to acquire two shares of
  evidence_url: https://www.sec.gov/Archives/edgar/data/1704287/000121390025098281/0001213900-25-098281-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.